VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

122 hedge funds and large institutions have $1.21B invested in Verve Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 29 reducing their positions, and 28 closing their positions.

Holders
122
Holders Change
-3
Holders Change %
-2.4%
% of All Funds
1.97%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
27
Increased
47
Reduced
29
Closed
28
Calls
$9M
Puts
$1.15M
Net Calls
+$7.85M
Net Calls Change
-$3.88M

Top Buyers

1
State Street
1
State Street
Massachusetts
$86.5M
2
AIM
2
ARK Investment Management
Florida
$84.5M
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$34.8M
4
APM
4
Avidity Partners Management
Texas
$30.3M
5
NAMA
5
Nikko Asset Management Americas
New York
$23.8M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$0
2
DM
2
Deerfield Management
New York
$0
3
PHS
3
PFM Health Sciences
California
$4.2M
4
CC
4
Casdin Capital
New York
$44.3M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$134M
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$7.63M +$1.76M +90,881 +30%
WP
27
Woodline Partners
California
$7.28M +$24.8K +1,282 +0.3%
Rafferty Asset Management
28
Rafferty Asset Management
New York
$7.21M +$3.75M +193,914 +108%
CAM
29
Cormorant Asset Management
Massachusetts
$6.77M -$4.84M -250,000 -42%
HRCM
30
Hood River Capital Management
Florida
$6.49M +$5.69M +293,955 +709%
Charles Schwab
31
Charles Schwab
California
$6.2M +$266K +13,724 +4%
AG
32
Artal Group
Luxembourg
$5.81M -$1.94M -100,000 -25%
GPP
33
Great Point Partners
Connecticut
$5.81M +$5.81M +300,000 New
JFG
34
Jefferies Financial Group
New York
$5.34M +$5.34M +275,713 New
GW
35
GW & Wade
Massachusetts
$5.02M +$213 +11 +0%
UBS Group
36
UBS Group
Switzerland
$4.72M +$4.06M +210,071 +623%
PHS
37
PFM Health Sciences
California
$4.2M -$18.4M -951,506 -81%
Barclays
38
Barclays
United Kingdom
$3.92M +$1.72M +88,718 +78%
Nuveen Asset Management
39
Nuveen Asset Management
Illinois
$3.65M -$2.13M -109,910 -37%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$3.37M +$87.3K +4,514 +3%
Citigroup
41
Citigroup
New York
$3.21M -$39.5K -2,041 -1%
Mirae Asset Global Investments
42
Mirae Asset Global Investments
South Korea
$3.03M +$387K +19,982 +15%
Morgan Stanley
43
Morgan Stanley
New York
$1.88M -$685K -35,383 -27%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.54M +$63.9K +3,300 +4%
AllianceBernstein
45
AllianceBernstein
Tennessee
$1.53M +$98.7K +5,100 +7%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$1.42M -$464K -23,993 -25%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.32M +$74.8K +3,866 +6%
ECM
48
ExodusPoint Capital Management
New York
$1.3M +$1.3M +67,344 New
TC
49
TwinBeech Capital
New York
$1.23M +$1.23M +63,343 New
CSS
50
Cubist Systematic Strategies
Connecticut
$1.11M +$715K +36,936 +183%
1
2
3 4 5